Vestal Point Capital »

Neurocrine Biosciences shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $165M 1.3M 131.74
2025-06-30 $3.8M 30k 125.69

More positions owned by Vestal Point Capital

Revolution Medicines (RVMD)
BioMarin Pharmaceutical (BMRN)
Abivax SA Sponsored Ads (ABVX)
Neurocrine Biosciences (NBIX)
Arrowhead Pharmaceuticals (ARWR)
Enliven Therapeutics (ELVN)
Repligen Corporation (RGEN)
Bicara Therapeutics (BCAX)
Nurix Therapeutics (NRIX)
Apogee Therapeutics (APGE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Immunocore Holdings Ads (IMCR)
Taysha Gene Therapies Com Shs (TSHA)
Dyne Therapeutics (DYN)
Sanofi SA Sponsored Adr (SNY)

View all positions for Vestal Point Capital

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Dodge & Cox
AQR Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Two Sigma Investments
Renaissance Technologies
Geode Capital Management
Wellington Management Company
Bellevue Group
Bnp Paribas Investment Partners
Vestal Point Capital
Millennium Management

View all funds holding Neurocrine Biosciences